An air of urgency has been visible at the Mumbai headquarters of the
second-largest Indian pharmaceutical company by sales, Lupin Ltd, for
the past three to four years.
Samina Vaziralli, grand-daughter of Cipla's founder Dr Khwaja Abdul
Hamied, had taken a break from her professional career as a banker.
At a time when Big Pharma is desperate for blockbuster breakthroughs and
viable business strategies, one Indian firm is basking in the knowledge
that its leadership baton will be passing into younger hands.
Arjun Juneja joined New Delhi-based Mankind Pharma in 2008 after
completing his Bachelor of Business Management from the University of
Bradford and MBA from the University of Strathclyde, UK.
Unlike many of the India Inc. successors who had got smoothly running
companies on a platter, Habil Khorakiwala's younger son Murtaza faced a
tough beginning.
Kiran Divi and Nilima Motaparti are under the spotlight. Indeed, all
eyes are on the son and daughter of Divi's Laboratories founder Murali
Divi.